The combination of anticancer drugs and TG1 promotes cytotoxicity against breast cancer cells because of its inhibitory effects on multidrug resistance, especially for p-glycoprotein drug efflux pump suppression. The gene discussed is ABCB1; the disease is breast carcinoma.